Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

7.8K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
7.8K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

678
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
678
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

535
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
535

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Challenges and Future Trends in Large Vessel Vasculitis.

Circulation·2026
Same author

Standardizing PSMA PET/CT reporting in prostate cancer: from structured frameworks to AI-assisted interpretation.

Abdominal radiology (New York)·2026
Same author

In vivo bacteria-targeted imaging with vancomycin-based positron emission tomography and optical tracers in an orthopaedic trauma implant infection model.

European journal of nuclear medicine and molecular imaging·2026
Same author

Positron emission tomography imaging of inflammation and infection in children: an update.

Seminars in nuclear medicine·2026
Same author

Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer.

Diagnostics (Basel, Switzerland)·2026
Same author

18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort Trial.

JAMA oncology·2026

Related Experiment Video

Updated: Mar 1, 2026

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography
09:41

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography

Published on: January 20, 2023

2.4K

PET in Benign Bone Marrow Disorders.

Wouter van der Bruggen1, Andor W J M Glaudemans2, Edo Vellenga3

  • 1Department of Nuclear Medicine, Slingeland Ziekenhuis, Doetinchem, The Netherlands.

Seminars in Nuclear Medicine
|June 7, 2017
PubMed
Summary
This summary is machine-generated.

Positron emission tomography (PET) offers valuable insights into benign bone marrow (BM) imaging, aiding in diagnosis and treatment monitoring for various BM disorders. Current tracers like FLT and FDG, alongside emerging PET agents and PET/MRI, show promise for enhanced BM visualization.

More Related Videos

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.3K
A Basic Positron Emission Tomography System Constructed to Locate a Radioactive Source in a Bi-dimensional Space
14:19

A Basic Positron Emission Tomography System Constructed to Locate a Radioactive Source in a Bi-dimensional Space

Published on: February 1, 2016

9.0K

Related Experiment Videos

Last Updated: Mar 1, 2026

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography
09:41

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography

Published on: January 20, 2023

2.4K
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.3K
A Basic Positron Emission Tomography System Constructed to Locate a Radioactive Source in a Bi-dimensional Space
14:19

A Basic Positron Emission Tomography System Constructed to Locate a Radioactive Source in a Bi-dimensional Space

Published on: February 1, 2016

9.0K

Area of Science:

  • Nuclear Medicine
  • Radiology
  • Hematology

Background:

  • Bone marrow (BM) imaging is crucial for understanding hematopoiesis and diagnosing primary and extramedullary diseases affecting the BM.
  • Positron emission tomography (PET) plays a significant role in evaluating benign BM disorders, including extramedullary hematopoiesis, BM infarctions, and treatment response.

Purpose of the Study:

  • To review the current applications and status of PET imaging in benign bone marrow disorders.
  • To highlight the utility of existing PET tracers and explore the potential of novel tracers and hybrid imaging techniques.

Main Methods:

  • Review of current literature on PET imaging in benign bone marrow conditions.
  • Discussion of established PET tracers such as 3'-18F-fluoro-3'-deoxy-L-thymidine (FLT) and 2-18F-2-deoxy-D-glucose (FDG).
  • Exploration of novel PET tracers (4DST, FAZA, MISO, ATSM) and the role of PET/MRI.

Main Results:

  • PET imaging is indicated for detecting extramedullary hematopoiesis, evaluating BM biopsies, diagnosing hematological disorders, and assessing treatment effects.
  • FLT-PET is effective for primary BM disorders, while FDG-PET reveals a higher prevalence of BM involvement in secondary benign diseases than previously recognized.
  • Novel tracers and PET/MRI offer improved specificity and visualization of benign BM pathology.

Conclusions:

  • PET imaging is a valuable tool for benign bone marrow disorders, with established tracers and promising new technologies.
  • Further clinical trials are needed to validate newer PET tracers and PET/MRI applications for routine use.
  • Updated guidelines for PET utilization in benign BM diseases are recommended.